CinnaPoietin®


(Erythropoietin β)

Protect yourself, faster and stronger


Description

Epoetin beta rch (recombinant human erythropoietin)

CAS registry number: 122312-54-3

CinnaPoietin® (epoetin beta rch) is a sterile, purified, stable recombinant human erythropoietin concentrate produced from genetically engineered Chinese hamster ovary (CHO) cells containing a cloned human erythropoietin gene.

The active ingredient, epoetin beta rch, is a highly purified glycoprotein, identical in amino acid sequence to endogenous erythropoietin, with a mean molecular weight of approximately 30kDa. Epoetin beta rch is 98% pure, with no detectable cell line residues.

CinnaPoietin® is available in pre-filled syringes containing the excipients urea, sodium chloride, sodium phosphate - monobasic, sodium phosphate - dibasic, calcium chloride, polysorbate 20, glycine, leucine, isoleucine, threonine, glutamic acid and phenylalanine.

 

Indication and Usage

  • Treatment of anemia associated with chronic kidney disease in adults and children on dialysis and symptomatic patients who have not undergone dialysis yet.
  • Prevention of anemia of prematurity in infants with a birth weight of 750 gr to 1500 gr and a gestational age of less than 34 weeks.
  • Treatment of anemia and reduction of transfusion requirements in adult patients with non-myeloid malignancies who are receiving chemotherapy, when the chemotherapy stops the bone marrow producing enough blood cells.
  • It can also be used in patients who are going to have an operation and donate their own blood before surgery (autologous blood transfusion) to increase the amount of blood that can be taken.

FAQs

more